Inhibitors of poly(adenosine diphosphate ribose) polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma.
D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D051379:Mice; D009244:NAD+ Nucleosidase / Q000037:antagonists & inhibitors*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
D001549:Benzamides; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D001761:Bleomycin; C025160:3-aminobenzamide; D009244:NAD+ Nucleosidase